{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:30:41Z","timestamp":1791862241259,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd008537","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,6,15]],"date-time":"2011-06-15T00:00:00Z","timestamp":1308096000000}}],"reference-count":44,"publisher":"Wiley","issue":"6","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008537.pub2","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T20:10:53Z","timestamp":1307477453000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Efficacy and safety of pharmacological interventions for the treatment of the Alcohol Withdrawal Syndrome"],"prefix":"10.1002","volume":"2011","author":[{"given":"Laura","family":"Amato","sequence":"first","affiliation":[{"name":"ASL RM\/E; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Minozzi","sequence":"additional","affiliation":[{"name":"ASL RM\/E; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Davoli","sequence":"additional","affiliation":[{"name":"ASL RM\/E; Department of Epidemiology; Via di Santa Costanza, 53 Rome Italy 00198"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,6,15]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0001|cit1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005063.pub3","article-title":"Benzodiazepines for alcohol withdrawal","author":"Amato","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0002|cit2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005190.pub2","article-title":"Psychotropic analgesic nitrous oxide for alcoholic withdrawal states","author":"Gillman","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006266.pub2","article-title":"Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses","author":"Leone","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0004|cit4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008502","article-title":"Baclofen for alcohol withdrawal","author":"Liu","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0005|cit5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005064.pub2","article-title":"Anticonvulsants for alcohol withdrawal","author":"Minozzi","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0006|cit6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004331","article-title":"Disulfiram for alcohol dependence","author":"Fox","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD008537.pub2-BIB0007|cit7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008581","article-title":"Antidepressants for the treatment of depression in alcohol dependent individuals","author":"Pani","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD008537.pub2-BIB0008|cit8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004332","article-title":"Acamprosate for Alcohol Dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD008537.pub2-BIB0009|cit9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001867.pub2","article-title":"Opioid antagonists for alcohol dependence","author":"R\u00f6sner","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007361.pub2","article-title":"Pharmacologic Interventions for Pregnant Women Enrolled in Alcohol Treatment","author":"Smith","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7454","key":"10.1002\/14651858.CD008537.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"GRADE Working Group. Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0012|cit12","first-page":"328","article-title":"The Efficacy and Safety of Topiramate in the Treatment of Alcohol Withdrawal","volume":"44","author":"Choi","year":"2005","journal-title":"Korean Database"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0031-9384(94)00215-Q","article-title":"Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol: occurrence within narrow dose ranges","volume":"57","author":"Colombo","year":"1995","journal-title":"Physiology & behavior"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0031-9384(98)00033-X","article-title":"Gammahydroxybutyricacid (GHB) intake in ethanol-preferring (sP) and -non preferring (sNP) rats","volume":"64","author":"Colombo","year":"1998","journal-title":"Physiology & behavior"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0149-7634(03)00030-7","article-title":"Alcohol and withdrawal: from animal research to clinical issues","volume":"27","author":"Witte","year":"2003","journal-title":"Neuroscience and Biobehavioral Reviews"},{"issue":"5-6","key":"10.1002\/14651858.CD008537.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0197-0186(00)00061-9","article-title":"Glutamate-mediated transmission, alcohol, and alcoholism","volume":"37","author":"Dodd","year":"2000","journal-title":"Neurochemistry International"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0017|cit17","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition revised.Washington, DC","author":"AA.VV","year":"1995"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0018|cit18","first-page":"133","article-title":"Differentaffinity of cortical GHB binding site in Sardinian alcohol-preferring (sP) and -non preferring (sNP) rats","volume":"30","author":"Frau","year":"1995","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0019|cit19","first-page":"787","article-title":"Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome","volume":"2","author":"Gallimberti","year":"1989","journal-title":"Lamcet"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1530-0277.1992.tb00658.x","article-title":"Gammahydroxybutyricacid in the treatment of alcohol dependence: a double-blind study.","volume":"16","author":"Gallimberti","year":"1992","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"5","key":"10.1002\/14651858.CD008537.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-2004-832597","article-title":"Polysomnography during withdrawal with chlormethiazole or placebo in alcohol dependent patients--a double-blind and randomised study \u00a0","volume":"37","author":"Gann","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"14","key":"10.1002\/14651858.CD008537.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0024-3205(86)90181-5","article-title":"Minireview: Analgesic (sub anaesthetic) nitrous oxide interacts with the endogenous opioid system : A review of the evidence","volume":"39","author":"Gillman","year":"1986","journal-title":"Life Sciences"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0023|cit23","first-page":"456","article-title":"Benzodiazepine receptor binding in the cerebellum in multiple system atrophy and olivopontocerebellar atrophy studied with positron emission tomography","volume":"69","author":"Gilman","year":"1996","journal-title":"Advances in Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD008537.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00207459808986412","article-title":"Clinical role and mechanisms of action of analgesic nitrous oxide.","volume":"93","author":"Gillman","year":"1998","journal-title":"International Journal of Neuroscience"},{"issue":"11","key":"10.1002\/14651858.CD008537.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1176\/ajp.147.11.1537","article-title":"The natural history of alcohol abuse: implications for definitions of alcohol use disorders","volume":"147","author":"Hasin","year":"1990","journal-title":"The American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD008537.pub2-BIB0026|cit26","first-page":"1054","article-title":"Metaanalysis of benzodiazepine use in the treatment of acute alcohol withdrawal","volume":"282","author":"Holbrook","year":"1999","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1001\/jama.280.3.278","article-title":"Methodology and reports of systematic reviews and meta-analyses:a comparison of Cochrane reviews with articles published in paper-based journals","volume":"280","author":"Jadad","year":"1998","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/106002809202600509","article-title":"Controversies over the use of magnesium sulphate in delirium tremens","volume":"26","author":"Jermain","year":"1992","journal-title":"Annals of Pharmacotherapy"},{"issue":"7","key":"10.1002\/14651858.CD008537.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1530-0277.2007.00419.x","article-title":"Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal:\u00a0 a double-blind, randomised, placebo-controlled multicenter pilot study","volume":"31","author":"Koethe","year":"2007","journal-title":"Alcoholism, Clinical and Experimental Research"},{"issue":"1-2","key":"10.1002\/14651858.CD008537.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050692","article-title":"Ethanol and negative feedback regulation of mesolimbic dopamine release in rats","volume":"139","author":"Kohl","year":"1998","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1176\/jnp.9.3.482","article-title":"The neurobiology of drug addiction","volume":"9","author":"Koob","year":"1997","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"issue":"5","key":"10.1002\/14651858.CD008537.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.pnpbp.2007.09.021","article-title":"New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medications","volume":"32","author":"Leggio","year":"2008","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/alcalc\/33.6.563","article-title":"Benzodiazepine treatment for alcohol dependent patients.","volume":"33","author":"Lejoyeux","year":"1998","journal-title":"Alcohol and Alcoholism"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","article-title":"Pharmacological management of alcohol withdrawal: a meta-analysis and evidence-based practice guideline.American Society of Addiction Medicine Working Group onPharmacological Management of Alcohol Withdrawal.","volume":"278","author":"Mayo-Smith","year":"1997","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD008537.pub2-BIB0035|cit35","first-page":"15","article-title":"Using a symptom-triggered approach to manage patients in acute alcohol withdrawal.","volume":"13","author":"McKay","year":"2004","journal-title":"Medical-Surgical Nurses"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1371\/journal.pmed.0040078","article-title":"Epidemiology and reporting characteristics of systematic reviews","volume":"4","author":"Moher","year":"2007","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1192\/bjp.175.2.114","article-title":"Alcohol and brain. Pharmacological insights for psychiatrists","volume":"175","author":"Nutt","year":"1999","journal-title":"The British Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD008537.pub2-BIB0038|cit38","first-page":"277","article-title":"Plasma gamma-aminobutyric acid (GABA) is low in alcoholics","volume":"29","author":"Petty","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0039|cit39","first-page":"263","article-title":"Magnesium deficiency in alcohol addiction and withdrawal","volume":"10","author":"Shane","year":"1991","journal-title":"Magnesium and Trace Elements"},{"issue":"7","key":"10.1002\/14651858.CD008537.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"15","author":"Shea","year":"2007","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD008537.pub2-BIB0041|cit41","unstructured":"Scottish Intercollegiate Guidelines Network (SIGN) The management of harmful drinking and alcohol dependence in primary care. A national clinical guideline www.sign.ac.uk 2003"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/alcalc\/34.3.289","article-title":"Effects of chronic ethanol exposure on neurophysiological responses to corticotropin-releasing factor and neuropeptide Y","volume":"34","author":"Slawecki","year":"1999","journal-title":"Alcohol and Alcoholism"},{"issue":"11","key":"10.1002\/14651858.CD008537.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).","volume":"84","author":"Sullivan","year":"1989","journal-title":"British Journal of Addiction"},{"issue":"3","key":"10.1002\/14651858.CD008537.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1176\/ajp.152.3.332","article-title":"The glutamatergic basis of human alcoholism.","volume":"152","author":"Tsai","year":"1995","journal-title":"The American Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD008537.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:02:37Z","timestamp":1769990557000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008537.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Drugs and Alcohol Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,6,15]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008537.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,15]]}}}